Inpatient Psych Outlook—PPS Reform, Mental Health Parity, Telehealth, EHR Compliance
This year, CMS will be working on reforms to the inpatient psych prospective payment system. Looking ahead to the forthcoming FY 2025 proposed rule, Marwood hosted a call with Shawn Coughlin, President and CEO of the National Association for Behavioral Healthcare, to discuss broader industry priorities for the sector.
Tuesday, March 19, 2024
11 ET
Key Takeaways
11 ET
A New European Regulatory Landscape For Artificial Intelligence
March 08, 2024
The European Union Artificial Intelligence Regulation, the world’s first comprehensive AI Regulation, will take effect from mid-2025 onwards with most of its provisions taking effect in 2026. In this piece, Marwood analyses the upcoming regulatory changes affecting AI systems in the EU and the potential impact it may have on companies developing or promoting AI applications in healthcare, or investors with existing or potential investments in these companies.
Health Insurance Claims Data and Practical Uses
March 07, 2024
Health insurance claims data are an increasingly widespread and valuable source of information for use in analyzing the healthcare space. This report presents an overview of health insurance claims data, including some of the specific sources integrated into Marwood’s analytics platform, and the possibilities for this data, understanding the complexities of a full patient encounter when undergoing a common esophagus endoscopy procedure.
Emerging Artificial Intelligence Applications In Preclinical Drug Development
February 20, 2024
AI in the life sciences has evolved from its roots in machine learning to applications of generative AI, natural language processing, deep learning and increasingly combinations of the latter 3. These tools are being applied to accelerate target discovery as well as improve design and processing, information aggregation and synthesis, as well as the repurposing of existing drugs. Herein we define and describe leading and emerging applications of AI in preclinical drug development and provide examples of models and companies shaping this burgeoning space.
Inpatient Rehab Outlook with AMRPA: Review Choice Demo Roll-Out, Landscape for MA Utilization, Case Mix Calculations, Early Discharge Penalty
Marwood hosted a call with Kate Beller, EVP of Policy Development and Government Relations at the American Medical Rehabilitation Providers Association, to discuss the forthcoming 2025 proposed rule and broader industry priorities.
February 22, 2024
11 ET
Key Takeaways
11 ET
HCBS Update with NAHC—Outlook for Payment Adequacy Standard Rule
Marwood’s Joe Mercer and Sherill Mason hosted a call with Damon Terzaghi, Director of Medicaid Advocacy at the National Association for Homecare and Hospice, to discuss provider priorities and different scenarios ahead of the anticipated Medicaid Home- and Community-Based Services (HCBS) payment adequacy final rule.
Thursday, February 15, 2024
11 a.m. ET
Key Takeaways
11 a.m. ET
Emerging AI Applications In Clinical Trials—CRO/SMO Considerations
February 05, 2024
Artificial intelligence is being adopted by clinical trial sponsors, clinical research organizations and site management organizations to drive efficiency. As well, AI-enhanced data analysis is a catalyst to the emergence of virtual trials and biosimulation. However, enablement is not without its regulatory and legislative challenges. Herein, we detail leading and emerging applications of AI in the clinical research space, and delineate regulatory and legislative trends shaping the industry.
The End Of Forever Chemicals In Europe, The Beginning Of New Investment Opportunities In The Medical Device Sector
January 31, 2024
PFAS are often used in medical devices because of their ‘non-stick’ quality. However, these chemicals are likely to be banned in Europe from 2025 as a result of their toxicity to humans and the environment. An EU-wide ban will force manufacturers to seek out PFAS-alternatives. This presents an upside for manufacturers of PFAS-free materials but may also introduce supply-chain disruptions and regulatory hurdles in the medium-term.
Medicare Advantage 2025 Advance Notice and Implications for Health Plans
We discussed the 2025 Medicare Advantage Advance Notice, reactions from the industry and policymakers and what it all means for health plans.
Tuesday, February 13, 2024
11 a.m. ET
Key Takeaways
11 a.m. ET
CATALYSTS: Health Policy Catalysts For The US, EU And UK
January 03, 2024
As we begin 2024, Marwood Group is pleased to share CATALYSTS: Health Policy Catalysts for the US, EU And UK. In the US, 2024 is likely to open with a flurry of activity before Congress slows pre-election, and the Biden administration looks to finalizing any outstanding policies. EU and the UK will see many changes introduced in health care regulation, reimbursement, and funding in sectors such as acute care hospitals, pharmaceuticals, social care and medical equipment.
How Urgent Care Centers Can Position For Continued Growth After COVID-19
January 03, 2024
Demand for urgent care services has increased over the last few years due to increased awareness of urgent care centers following the COVID-19 pandemic, as well as shifting consumer preferences and payor steerage toward urgent care over alternative care settings. Although increased demand has led to some saturated markets, expansion of service offerings, such as primary care add-ons and joint ventures with hospitals, positions the urgent care market for continued growth.
Emerging Artificial Intelligence Applications In Pharmacy
December 20, 2023
Through emerging artificial intelligence (AI) tools, pharmacies will enhance their operational capabilities across limited labor and better allocate pharmacist time toward potential improvements in not only productivity, but patient outcomes. Target analysis in this environment requires an understanding of not only the emerging AI market and its applications, but federal and state regulatory and legislative trends shaping this emerging technology.
Marwood at 42nd Annual JP Morgan Healthcare Conference
Select members of our senior executive team were joined by Marwood's subject matter experts across various subsectors for meetings in San Francisco.
January 8-10, 2024
Key Takeaways
Payor Adoption of Artificial Intelligence And Its Impact On Provider Organizations
November 29, 2023
Payor investment into AI is a consideration not only to those with a direct stake in payors and the vendors which serve them, but to those invested in provider organizations which payor impacts may touch. Target analysis in this environment requires not only an understanding of payor applications, market and both federal and state regulatory and legislative trends, but a clear grasp on billing and coding. Herein we address key areas of AI innovation by payors and the potential impacts on providers.
Healthcare Policies in the Wake of Spain’s 2023 General Election
November 10, 2023
Marwood takes a deeper look at the key health policy proposals in the PSOE-Sumar Pact that could be pursued in Spain's next legislature. Even if the ultimate jurisdiction and decision-making power remains with Autonomous Communities, a PSOE-Sumar coalition could push elements within the Pact, marking the direction of travel for Spanish health policy over the next 4 years.
Legislative Outlook: November 17 CR and Year-End Congressional Priorities, Opportunities for Provider Relief; Landscape for 2024
Our senior analysts discussed the outlook for the November Continuing Resolution, as well as Congressional priorities expected to pass year-end vs. 2024.
Tuesday, November 14, 2023
11 a.m. ET
Key Takeaways
11 a.m. ET
The Compass: Healthcare Insights for Europe
November 01, 2023
The drive towards cost-containment, improved quality and safety, and equity of access in healthcare - all while trying to keep pace with innovation in digital health, medical devices, and pharmaceuticals - has resulted in regulations, policies, and revamped funding structures that will have broad and lasting impact across European markets. Our Compass publication aims to act as an important reference document to chart a path through the complex healthcare waters of the EU and UK.
Marwood at HLTH 2023
Marwood sponsored HLTH 2023, discussing opportunities and solutions across the healthcare marketplace.
October 8–10, 2023 | Las Vegas
Key Takeaways
Navigating Medicare Advantage Risk Adjustment
Marwood and the Alliance of Community Health Plans hosted a webinar focused on CMS modernization, and the past, present, and future of MA risk adjustment
September 12, 2023
11 a.m. ET
Key Takeaways
11 a.m. ET
Marwood at Goldman’s European MedTech and Healthcare Services Conference
Marwood’s senior analysts discussed top-of-mind catalysts impacting health care, as well as other key issues, ahead of what is expected to be an active autumn and year-end in Washington DC.
September 6-7, 2023 | London
Key Takeaways
Opportunities In Fertility Services – Regulatory Considerations For Surrogacy Agencies
August 23, 2023
Surrogacy has become an increasingly popular fertility service that enjoys positive regulatory environments across much of the country.
The NHS Long Term Workforce Plan: Plugging The Gap In England’s Healthcare Sector
August 01, 2023
The National Health Service (NHS) Long Term Workforce Plan published in Summer 2023 will impact not only on England’s public healthcare sector but also on the independent healthcare sector. In this piece, Marwood analyses the potential impacts on England’s health and care workforce and identifies the key takeaways for investors considering assets in this market.
Florida Medicaid Update with SNHAF
Key themes from redetermination reports, enrollment impacts; outlook for hospitals, safety net providers
Tuesday, August 1, 2023
1 p.m. ET
Key Takeaways
1 p.m. ET
Home Health 2024 Proposed Rule Review
Key takeaways, outlook for behavioral adjustment and budget neutrality; industry impacts
Tuesday, July 5, 2023
11 a.m. ET
Inquire About Key Takeaways
11 a.m. ET
Artificial Intelligence in Healthcare Worker Sourcing and Staffing
June 28, 2023
The healthcare sector is undergoing a chronic labor shortage with a systematic training lag limiting the expansion of the skilled workforce for the foreseeable business cycle.
Advances In Weight Loss Drug Development And The Impact On Provider Services
June 14, 2023
Excess body weight afflicts more than two-thirds of Americans. Until recently, pharmacological interventions have been incremental at best. In 2021, the FDA approved Wegovy (semaglutide) for chronic weight management, delivering the first results even remotely comparable to bariatric surgery.
Opportunities in Fertility Services: The Importance of State-Level Analysis
May 24, 2023
Demand for fertility services has grown over the last few years, along with increasing insurance coverage mandates and rising interest from large employer groups. In the absence of federal policy, states have taken on a more active role in requiring commercial coverage and reimbursement of infertility treatment.
Opportunities For Growth And Consolidation In The Cosmetic Surgery & Medspa Market
May 02, 2023
While cosmetic surgery & medspa procedure platforms have rarely achieved scale to date, they are a growing area of investor focus, supported by an aging population and positive consumer trends in aesthetics catalyzed through the COVID-19 pandemic.
Diagnostic Radiopharmacy: Overview And Market Access Considerations
April 04, 2023
Nuclear medicine utilizes radioactive tracers (radiopharmaceuticals) to assess systemic functions as well as to diagnose and treat disease.
Claims Data Analytics in Target Evaluation: A Case Study in Center-Based Orthopedics
January 06, 2023
Orthopedic practices are a growing area of investor focus, supported by an aging population and positive reimbursement dynamics, particularly in the outpatient setting. Herein, Marwood presents its proprietary analytics platform for reimbursement claims analysis through a case study of the outpatient orthopedics space in North Carolina.
Sign Up for Marwood's Healthcare Newsletter